Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic
- 4 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (4) , 2110-2124
Abstract
Neurotensin (NT) receptor type 2 (NTS2) represents an attractive target for the development of new NT-based analgesics. Here, we report the synthesis and functional in vivo characterization of the first constrained NTS2-selective macrocyclic NT analog. While most chemical optimization studies rely on the NT(8-13) fragment, we focused on NT(7-12) as a scaffold to design NTS2-selective macrocyclic peptides. Replacement of Ile12 by Leu, and Pro7/Pro10 by allylglycine residues followed by cyclization via ring-closing metathesis led to macrocycle 4, which exhibits good affinity for NTS2 (50 nM), high selectivity over NTS1 (>100 μM), and improved stability compared to NT(8-13). In vivo profiling in rats reveals that macrocycle 4 produces potent analgesia in three distinct rodent pain models, without causing the undesired effects associated with NTS1 activation. We further provide evidence of its non-opioid antinociceptive activity, therefore highlighting the strong therapeutic potential of NTS2-selective analogs for the management of acute and chronic pain.Keywords
Funding Information
- Canadian Institutes of Health Research (FDN-148413)
- Santé
- Canada Foundation for Innovation
- Natural Sciences and Engineering Research Council of Canada
This publication has 103 references indexed in Scilit:
- Spinal NTS2 receptor activation reverses signs of neuropathic painThe FASEB Journal, 2013
- Structure of the agonist-bound neurotensin receptorNature, 2012
- Discovery of Highly Potent and Neurotensin Receptor 2 Selective Neurotensin MimeticsJournal of Medicinal Chemistry, 2011
- Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligandOrganic & Biomolecular Chemistry, 2011
- Extended-release morphine sulfate in treatment of severe acute and chronic painJournal of Pain Research, 2010
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- NT79: A novel neurotensin analog with selective behavioral effectsBrain Research, 2010
- Evidence for a Role of NTS2 Receptors in the Modulation of Tonic Pain SensitivityMolecular Pain, 2009
- Influence of proline residues on protein conformationJournal of Molecular Biology, 1991
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973